Statins Could Prevent More Strokes, Heart Attacks: Analysis

Business Week

Broader use of cholesterol-lowering statins may be a cost-effective way to prevent heart attack and stroke, U.S. researchers suggest.

In the study, published online Sept. 27 in the journal Circulation, the researchers also found that screening for high sensitivity C-reactive protein (CRP) to identify patients who may benefit from statin therapy is only cost-effective in certain cases. Elevated levels of CRP indicate inflammation and suggest an increased risk for heart attack and stroke.

Currently, statin therapy is recommended for high-risk patients -- those with a 20 percent or greater risk of some type of cardiovascular event within the next 10 years. But statins may also benefit people with a lower risk, according to Dr. Mark Hlatky, professor of health research and policy and of cardiovascular medicine at Stanford University School of Medicine in Stanford, Calif., and colleagues.

Hlatky's team set out to determine the cost-effectiveness of three statin therapy approaches in patients with normal cholesterol levels and no evidence of heart disease or diabetes: following current guidelines; conducting CRP screening in patients who don't meet current statin treatment guidelines and offering statins to those with elevated CRP levels; and providing statin therapy based on a patient's cardiovascular risk alone, with no CRP testing.

Read Full Story…

 

All active news articles

Get Involved

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.